Caricamento...
Case Report: Severe Rashes Associated With Fruquintinib in a Patient With Metastatic Colorectal Cancer
Metastatic colorectal cancer (mCRC) is a common and high-risk malignant tumor. Fruquintinib is a novel small-molecule compound with high selective inhibition of vascular endothelial growth factor (VEGF) receptor (VEGFR) for mCRC for which second-line or higher standard chemotherapy has been ineffect...
Salvato in:
| Pubblicato in: | Front Oncol |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Frontiers Media S.A.
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8288029/ https://ncbi.nlm.nih.gov/pubmed/34290985 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.688231 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|